Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02221349 · ClinicalTrials.gov registry record · NA
A Clinical Study of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02221349: Completed NA study, sponsored by Procter and Gamble.
NCT02221349 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02221349, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will compare the safety and effectiveness of normal oral hygiene with two different marketed dentifrices, on longer term dentinal hypersensitivity response following use of potassium oxalate desensitizers.
Primary Outcome
The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows: 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subjects responds to stimulus and requests discontinuation or moves from stimulus, 3: tooth/subject respon
Interventions
- DEVICE Potassium oxalate
- DRUG Stannous fluoride paste
- DRUG Sodium fluoride paste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-08 |
| Est. Completion | 2014-10 |
| Phase | NA |
What the finished NCT02221349 record still lists
NCT02221349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Potassium oxalate is the first listed.
NCT02221349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02221349 about?
NCT02221349 is a clinical study titled "A Clinical Study of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene". This study will compare the safety and effectiveness of normal oral hygiene with two different marketed dentifrices, on longer term dentinal hypersensitivity response following use of potassium oxalate desensitizers.
What is the current status of trial NCT02221349?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-08. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02221349?
The interventions under investigation include: Potassium oxalate (DEVICE), Stannous fluoride paste (DRUG), Sodium fluoride paste (DRUG).
Who is sponsoring clinical trial NCT02221349?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02221349's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia